Navigation Links
FDA Approves 1st Skin Patch to Combat Migraines
Date:1/21/2013

By Amanda Gardner
HealthDay Reporter

MONDAY, Jan. 21 (HealthDay News) -- A skin patch for the treatment of migraines, and the intense waves of nausea that often accompany these debilitating headaches, has been approved by the U.S. Food and Drug Administration.

Called Zecuity, the patch contains sumatriptan, one of the most widely prescribed medications for migraines.

According to Dr. Fawad Khan, a neurologist with Ochsner Neuroscience Institute in New Orleans, few drugs are approved for the treatment of acute, symptomatic migraine. To complicate matters, many migraine sufferers can also experience severe bouts of nausea and vomiting.

Another expert described the problem this way.

"I've had some patients where the nausea and vomiting was so bad they couldn't even swallow a pill," said Nancy Waltman, a nurse practitioner with the University of Nebraska Medical Center College of Nursing, Lincoln Division.

A nasal spray is available, as is an injection, but many patients aren't comfortable with these options, Khan and Waltman noted.

Khan said the Zecuity patch is "simple, efficient and can deliver the exact amount of dosage with minimal variability."

The patch is attached to the upper arm or thigh, and when the patient pushes a button the drug is delivered through the skin. Zecuity, which is battery-operated, delivers 6.5 milligrams of sumatriptan over the course of about five hours and can relieve nausea, as well as reduce sensitivity to light and sound.

NuPathe Inc., which makes Zecuity, hopes to have the patch on the market later this year.

Research involving 800 patients ultimately led to the approval of Zecuity. One study found that 18 percent of patients using the patch were headache-free after two hours, compared with 9 percent of those using an inactive placebo. About half achieved a reduction in their headache after two hours, compared with 29 percent of those using the
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Environmental Protection Agency Approves MOMS by OdorXit as a Disinfectant
2. FDA Approves New Type of Flu Vaccine
3. FDA Approves New Once-a-Day HIV Pill
4. FDA Approves Flu Vaccine for Coming Season
5. FDA Approves 2nd New Weight-Loss Drug
6. FDA Approves 1st Pill to Help Prevent HIV Infection
7. FDA Approves First New Weight-Loss Drug in More Than a Decade
8. FDA Approves SonixGPS Needle Guidance Technology for Vascular Access Procedures
9. FDA Approves Combo Shot for Meningitis, Hib in Kids
10. FDA Approves Generic Versions of Plavix
11. Measles vaccine given with a microneedle patch could boost immunization programs
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Approves 1st Skin Patch to Combat Migraines
(Date:7/28/2014)... promises to be bigger, better and more interactive than ... Congress Programme Committee. The European Society of Cardiology hosts ... year in August. Record numbers of Hot Line sessions ... is on track to host the largest number of ... extra hot line session has been added this year, ...
(Date:7/28/2014)... UK, have devised a simple blood test that ... or not. , The test will enable ... certain symptoms, saving time and preventing costly and unnecessary ... out. Alternatively, it could be a useful aid for ... that is currently hard to diagnose. , Early ...
(Date:7/28/2014)... 28, 2014 Axiom EPM , ... planning and performance management software for enterprises, today announced ... achieving results that surpassed its record Q1 results, and ... company attributes this growth to increased demand for its ... as the addition of incremental solutions for existing customers. ...
(Date:7/28/2014)... 2014 Freeonlinelifeinsuranceleads.com has released a ... online life insurance quotes. , Comparing life insurance quotes ... life insurance costs. Finding affordable coverage is easier online ... from reliable agencies and displays them on a single ... clients can find cheaper coverage, but they can also ...
(Date:7/28/2014)... Dennis Thompson HealthDay ... The U.S. Supreme Court,s ruling on contraception coverage -- as ... a legal quagmire that might allow companies to deny insurance ... some health care experts say. But other experts counter ... justices ruled 5-4 last month that Hobby Lobby Stores Inc. ...
Breaking Medicine News(10 mins):Health News:ESC Congress 2014 focuses on innovations in cardiology 2Health News:ESC Congress 2014 focuses on innovations in cardiology 3Health News:Potential 'universal' blood test for cancer discovered 2Health News:Potential 'universal' blood test for cancer discovered 3Health News:Axiom EPM Announces Record Second Quarter of 2014 2Health News:Comparing Life Insurance Quotes Online Offers 3 Important Advantages! 2Health News:The 'Hobby Lobby Ruling' and What It Means for U.S. Health Care 2Health News:The 'Hobby Lobby Ruling' and What It Means for U.S. Health Care 3Health News:The 'Hobby Lobby Ruling' and What It Means for U.S. Health Care 4Health News:The 'Hobby Lobby Ruling' and What It Means for U.S. Health Care 5
... who have recurrent fevers are less likely to develop ... National Institutes of Health studied more than 830 children ... fever-related episodes. Researchers defined fever as a temperature of ... evaluated again for allergies when they were between ages ...
... the cardiovascular system in seniors by lowering // blood levels ... ages 70 to 79 who consumed moderate levels of alcohol ... alcohol (more than eight drinks per week), and did not ... the first to focus on the association between alcohol intake ...
... Taiwanese experts , people buying the popular herbal medicine may ... Hypericum, can have mild antidepressant effects, although doctors warn it ... the tablets tested had as much of the active ingredient ... thought to be responsible for the psychoactive effects of St ...
... the use of hormone replacement therapy among breast cancer survivors ... high rate of recurring or new cancers. ,Swedish researchers ... surviving the disease and therefore subject to the same menopausal ... around 1,300 women over five years. After the initial 345 ...
... by eating beef from cattle with mad cow disease ... infected individuals, say researchers according to a recent study. ... the variant form of Creutzfeldt-Jakob disease (vCJD), which has ... with bovine spongiform encephalopathy (BSE), can be transmitted through ...
... potentially fatal disease caused by bacteria. It can attack any ... say beginning in the 1940s with the discovery of antiviral ... States. However, it began to reappear in the 1980s when ... of HIV.However, the incidence of TB has declined since ...
Cached Medicine News:
(Date:7/28/2014)... July 28, 2014 PDL BioPharma, Inc. (PDL) (NASDAQ: ... release its second quarter 2014 financial results for the period ... market close. PDL,s management will host a conference call and ... the financial results.  A slide presentation relating to the call ... website. Conference Call Details To access the ...
(Date:7/28/2014)... , July 28, 2014  ProteinSimple announced today that ... Simple Western. This new assay allows users to detect all ... time, Simple Western users can analyze proteins without the ... Western has changed protein analysis as we know it ... blot protocols - no messy gels, no transfer tanks, ...
(Date:7/28/2014)... HILDEN , Germany and ... -- , Collaboration aims to ... plasma samples to guide the use of IRESSA  for ... test will build on QIAGEN,s FDA-approved  therascreen   EGFR test ... QIAsymphony family of automated instruments  Project enabled ...
Breaking Medicine Technology:PDL BioPharma to Announce Second Quarter 2014 Financial Results on August 11, 2014 2ProteinSimple Says "Never Run a Gel Again!" 2QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 2QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 3QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 4QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 5QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 6
... 2011 /PRNewswire-USNewswire / -- Today, Sigma-Tau Pharmaceuticals, ... with Acute Lymphoblastic Leukemia (ALL).  The Sigma-Tau Outreach ... percent of any co-pay associated with their prescription ... please call 1-800-490-3262, Monday through Friday, 9 a.m. ...
... FacilityONE has been selected by Englewood, Colo.-based ... national Computerized Maintenance Management System. FacilityONE was chosen from ... of CHI executives. "FacilityONE is the ... Smith, CHI,s Vice President, Supply Chain - Clinical Engineering/Facility ...
Cached Medicine Technology:Financial Assistance Now Available for People with Acute Lymphoblastic Leukemia 2Financial Assistance Now Available for People with Acute Lymphoblastic Leukemia 3Financial Assistance Now Available for People with Acute Lymphoblastic Leukemia 4FacilityONE® Wins Major Healthcare Customer 2
... two perforations which enable procedure-specific ... single or bilateral configurations to ... has two perforations which enable ... various single or bilateral configurations ...
Unique 2 in 1 design allows simultaneous absorption of excess fluid & protection of flap & hinge, Lint-free PVAmaterial....
Angled 45, 9mm from end, Longer design from bend to tip allows for easier placement of viscoelastic to all meridians, Dome shape, extra smooth tip...
Dome shape, extra smooth tip provides safe insertion through wound & manipulation within the eye. 45, 4.0mm from end...
Medicine Products: